Cheng Kenneth T.
National Center for Biotechnology Information, NLM, NIH, Bethesda, MD,
Indocyanine 7 (Cy7)–tetrameric arginine-glycine-aspartic acid peptide (Cy7 E{E[c(RGDyK)]}) is an integrin-targeted molecular imaging agent developed for near-infrared (NIR) fluorescence imaging of tumor vasculature and tumor angiogenesis (1). Cy7 has a peak excitation wavelength of 743 nm and a peak emission wavelength of 767 nm. Cellular survival, invasion, and migration control embryonic development, angiogenesis, tumor metastasis, and other physiologic processes (2, 3). Among the molecules that regulate angiogenesis are integrins, which comprise a superfamily of cell adhesion proteins that form heterodimeric receptors for extracellular matrix (ECM) molecules (4, 5). These transmembrane glycoproteins consist of two noncovalently associated subunits, α and β (18 α- and 8 β-subunits in mammals), which are assembled into at least 24 α/β pairs. Several integrins, such as integrin αβ, have affinity for the arginine-glycine-aspartic acid (RGD) tripeptide motif, which is found in many ECM proteins. Expression of integrin αβ receptors on endothelial cells is stimulated by angiogenic factors and environments. The integrin αβ receptor is generally not found in normal tissue, but it is strongly expressed in vessels with increased angiogenesis, such as tumor vasculature. It is significantly upregulated in certain types of tumor cells and in almost all tumor vasculature. Molecular imaging probes carrying the RGD motif that binds to the integrin αβ can be used to image tumor vasculature and evaluate angiogenic response to tumor therapy (6, 7). Various RGD peptides in both linear and cyclic forms have been developed for binding to integrin αβ (8). It has been hypothesized that cyclic RGD peptide may have a faster rate of receptor binding or a slower rate of dissociation from the integrin αβ than linear single RGD peptides (9). Wu et al. (9) proposed to evaluated whether a multimeric RGD peptide with >2 repeating cyclic RGD units would further enhance the affinity of the receptor-ligand interactions through a polyvalency effect. They also suggested that the increase in molecular size might prolong circulation time and reduce tumor washout rate. Optical imaging is an imaging method that utilizes light photons emitted from bioluminescence and fluorescence probes (7). Depth penetration is one major limiting factor in optical imaging. Currently, optical imaging has wide applications in small animal imaging but only limited applications in large animal and human studies (10). NIR fluorescence imaging (light range, 650−900 nm) has the advantages of relatively higher tissue penetration and lower autofluorescence from nontarget tissue. NIR fluorescent dyes conjugated RGD peptides such as Cy5.5-c(RGDyK), Cy5.5-c(RGDfK), and Cyp-GRD have been shown to visualize subcutaneously implanted integrin αβ−positive tumors (11-14). Wu et al. (1) investigated the use of the NIR fluorescent dye Cy7−conjugated tetrameric RGD to detect tumor integrin expression. Cy7 was chosen because of its deeper tissue penetration, lower scattering effect, and lower background autofluorescence compared to Cy5.5. The polyvalency effect and suitable apparent size of Cy7-E{E[c(RGDyK)]} appeared to make it a highly potent integrin αβ probe.
吲哚菁绿7(Cy7)-四聚体精氨酸-甘氨酸-天冬氨酸肽(Cy7 E{E[c(RGDyK)]})是一种靶向整合素的分子成像剂,用于肿瘤血管和肿瘤血管生成的近红外(NIR)荧光成像(1)。Cy7的峰值激发波长为743 nm,峰值发射波长为767 nm。细胞存活、侵袭和迁移控制着胚胎发育、血管生成、肿瘤转移及其他生理过程(2, 3)。整合素是调节血管生成的分子之一,它是一类细胞黏附蛋白超家族,可形成细胞外基质(ECM)分子的异二聚体受体(4, 5)。这些跨膜糖蛋白由两个非共价结合的亚基α和β组成(哺乳动物中有18种α亚基和8种β亚基),它们组装成至少24种α/β对。几种整合素,如整合素αβ,对许多ECM蛋白中存在的精氨酸-甘氨酸-天冬氨酸(RGD)三肽基序具有亲和力。血管生成因子和环境可刺激内皮细胞上整合素αβ受体的表达。整合素αβ受体在正常组织中通常不存在,但在血管生成增加的血管中强烈表达,如肿瘤血管。它在某些类型的肿瘤细胞和几乎所有肿瘤血管中均显著上调。携带与整合素αβ结合的RGD基序的分子成像探针可用于成像肿瘤血管并评估对肿瘤治疗的血管生成反应(6, 7)。已开发出线性和环状形式的各种RGD肽用于与整合素αβ结合(8)。据推测,环状RGD肽与整合素αβ的受体结合速率可能比线性单RGD肽更快,或解离速率更慢(9)。Wu等人(9)提议评估具有>2个重复环状RGD单元的多聚体RGD肽是否会通过多价效应进一步增强受体-配体相互作用的亲和力。他们还表明,分子大小的增加可能会延长循环时间并降低肿瘤洗脱率。光学成像是一种利用生物发光和荧光探针发射的光子的成像方法(7)。深度穿透是光学成像的一个主要限制因素。目前,光学成像在小动物成像中有广泛应用,但在大型动物和人体研究中的应用有限(10)。近红外荧光成像(光范围为650−900 nm)具有相对较高的组织穿透性和较低的非靶组织自发荧光的优点。已证明与RGD肽偶联的近红外荧光染料,如Cy5.5-c(RGDyK)、Cy5.5-c(RGDfK)和Cyp-GRD,可使皮下植入的整合素αβ阳性肿瘤可视化(11 - 14)。Wu等人(1)研究了使用近红外荧光染料Cy7偶联的四聚体RGD来检测肿瘤整合素表达。选择Cy7是因为与Cy5.5相比,它具有更深的组织穿透性、更低的散射效应和更低的背景自发荧光。Cy7-E{E[c(RGDyK)]}的多价效应和合适的表观大小似乎使其成为一种高效的整合素αβ探针。